Handbook of Clinical medicine
KEYWORDS: patient, disease, patients, history, pain, heart, symptoms, ask, time, treatment, risk, examination, aortic, iinnddbb, pulse

Antihistone Ab: drug-induced SLE (~100%). Antiphospholipid Ab (eg anti-cardiolipin Ab): antiphospholipid syndrome, SLE. Anticentromere Ab: limited systemic sclerosis. Anti-extractable nuclear antigen (ENA) antibodies (usually with +ve ANA): • Anti-Ro (SSA) SLE, Sjögren’s syndrome, systemic sclerosis. Associated with congenital heart block. • Anti-La (SSB) Sjögren’s syndrome, SLE (15%). • Anti-Sm SLE (20–30%). • Anti-RNP SLE, mixed connective tissue disease. • Anti Jo-1; Anti-Mi-2 Polymyositis, dermatomyositis. • Anti-Scl70 Diff use systemic sclerosis. Gastrointestinal: (For liver autoantibodies, see p284.) Antimitochondrial Ab (AMA): primary biliary cholangitis (>95%), autoimmune hepatitis (30%), idiopathic cirrhosis (25–30%). Anti-smooth muscle Ab (SMA): autoimmune hepatitis (70%), primary biliary chol- angitis (50%), idiopathic cirrhosis (25–30%). Gastric parietal cell Ab: pernicious anaemia (>90%), atrophic gastritis (40%), ‘normal’ (10%). Intrinsic factor Ab: pernicious anaemia (50%). -gliadin Ab, antitissue transglutaminase, anti-endomysial Ab: coeliac disease. Endocrine: Thyroid peroxidase Ab: Hashimoto’s thyroiditis (~87%), Graves’ (>50%). Islet cell Ab (ICA), glutamic acid decarboxylase (GAD) Ab: type 1 diabetes mellitus (75%). Renal: Glomerular basement membrane Ab (anti-GBM): Goodpasture’s disease (100%). Antineutrophil cytoplasmic Ab (ANCA): • Cytoplasmic (cANCA), specifi c for serine proteinase-3 (PR3 +ve). Granulom atosis with polyangiitis(Wegener’s) (90%);also microscopic polyangiitis(30%),pol- yarteritis nodosa (11%). • Perinuclear (pANCA), specifi c for myeloperoxidase (MPO +ve). Microscopic poly- angiitis (45%), Churg–Strauss,
